Suchergebnisse - "Yates, James W T"

PubPharm (111)

51

Accounting for dropout in xenografted tumour efficacy studies: integrated endpoint analysis, reduced bias and better use of animals

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Martin, E. | Aarons, L. | Yates, J.

52

Accounting for dropout in xenografted tumour efficacy studies: integrated endpoint analysis, reduced bias and better use of animals

enthalten in: Cancer chemotherapy and pharmacology | 2016

von Martin, E. | Aarons, L. | Yates, J.

53

Designing More Efficient Preclinical Experiments : A Simulation Study in Chemotherapy-Induced Myelosupression

enthalten in: Toxicological sciences : an official journal of the Society of Toxicology | 2016

von Martin, E. | Aarons, L. | Yates, J.

54

AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER+ Breast Cancer When Administered Using Intermittent or Continuous Schedules

enthalten in: Molecular cancer therapeutics | 2015

von Guichard, S. | Curwen, J. | Bihani, T. | +15

55

Oxygen-Driven Tumour Growth Model : A Pathology-Relevant Mathematical Approach

enthalten in: PLoS computational biology | 2015

von Delgado-SanMartin, J. | Hare, J. | de Moura, A. | +1

56

Validation of a predictive modeling approach to demonstrate the relative efficacy of three different schedules of the AKT inhibitor AZD5363

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yates, J. | Dudley, P. | Cheng, J. | +2

57

Tumour stromal morphology impacts nanomedicine cytotoxicity in patient-derived xenografts

enthalten in: Nanomedicine : nanotechnology, biology, and medicine | 2015

von Delgado San Martin, J. | Hare, J. | Yates, J. | +1

58

Validation of a predictive modeling approach to demonstrate the relative efficacy of three different schedules of the AKT inhibitor AZD5363

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yates, J. | Dudley, P. | Cheng, J. | +2

59

Validation of a predictive modeling approach to demonstrate the relative efficacy of three different schedules of the AKT inhibitor AZD5363

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yates, J. | Dudley, P. | Cheng, J. | +2

60

Validation of a predictive modeling approach to demonstrate the relative efficacy of three different schedules of the AKT inhibitor AZD5363

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Yates, J. | Dudley, P. | Cheng, J. | +2